Austin TX 超重临床试验
19项针对 超重的研究正在 Austin及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
招募中3 期
- Pinnacle Clinical Research Georgetown, Austin
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- IMA Clinical Research Austin, Austin
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
招募中3 期
- FutureSearch Trials of Neurology, Austin
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- Dell Children's Medical Center - PIN, Austin
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Elligo Clinical Research Center /ID# 282166, Austin
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Austin
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
招募中1 期
- Elligo Clin Res Centre, Austin
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- IMA Clinical Research Austin, Austin
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- IMA Clinical Research Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Elligo Clinical Research Center, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- Elligo Clinical Research Center, Austin
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Texas Diabetes & Endocrinology, Austin
Semaglutide for Post-Smoking Cessation Weight Management
招募中2 期欢迎健康志愿者
- The University of Texas at Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Austin
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Austin
- ACCOMPLISH-1 Research Site, Austin
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
招募中1 期
- Corxel Investigational Site, Austin
其他城市的 超重试验
- San Antonio, TX34 项研究
- Houston, TX33 项研究
- Chicago, IL29 项研究
- Orlando, FL27 项研究
- Dallas, TX23 项研究
- Miami, FL23 项研究
- Washington, DC20 项研究
- Atlanta, GA20 项研究
- Las Vegas, NV19 项研究
- Jacksonville, FL19 项研究
- New York City, NY19 项研究
- Los Angeles, CA18 项研究
Austin的其他研究
- 非小细胞肺癌29 项研究
- 癌症（所有类型）22 项研究
- 肥胖症22 项研究
- 转移性癌症18 项研究
- 结直肠癌17 项研究
- 卵巢癌17 项研究
- 心力衰竭17 项研究
- 子宫内膜癌15 项研究
- 乳腺癌15 项研究
- 2型糖尿病14 项研究
- 前列腺癌14 项研究
- 脂肪性肝病13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。